Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal of the Optical Society of America. A, Optics, Image Science, and Vision|March 5, 2013
Spectral reflectivity recovery from the tristimulus values using a hybrid methodBog G Kim, Jeong-won Han, Soo-been Park
Scientific Reports|September 9, 2017
CG200745, an HDAC inhibitor, induces anti-tumour effects in cholangiocarcinoma cell lines via miRNAs targeting the Hippo pathwayDawoon E Jung, Soo Been Park, Kahee Kim, et al.
Scandinavian Journal of Gastroenterology|January 24, 2017
Sorafenib inhibits 5-fluorouracil-resistant gastric cancer cell growthHee Man Kim, Sun A Kim, Soo Been Park, et al.
Oncotarget|November 5, 2017
Suppression of pancreatic adenocarcinoma upregulated factor (PAUF) increases the sensitivity of pancreatic cancer to gemcitabine and 5FU, and inhibits the formation of pancreatic cancer stem like cellsJae Hee Cho, Sun A Kim, Soo Been Park, et al.
International Journal of Molecular Sciences|January 27, 2021
Identification of Circulating Serum miRNAs as Novel Biomarkers in Pancreatic Cancer Using a Penalized AlgorithmJaehoon Lee, Hee Seung Lee, Soo Been Park, et al.
International Journal of Molecular Sciences|January 31, 2019
Novel Gastric Cancer Stem Cell-Related Marker LINGO2 Is Associated with Cancer Cell Phenotype and Patient OutcomeJung Hyun Jo, Soo Been Park, Semi Park, et al.
BMC Medical Genomics|May 18, 2019
Identification of potential biomarkers for diagnosis of pancreatic and biliary tract cancers by sequencing of serum microRNAsKwondo Kim, DongAhn Yoo, Hee Seung Lee, et al.
Scientific Reports|January 31, 2017
A novel HDAC inhibitor, CG200745, inhibits pancreatic cancer cell growth and overcomes gemcitabine resistanceHee Seung Lee, Soo Been Park, Sun A Kim, et al.
NPJ Precision Oncology|August 1, 2024
PUM1-TRAF3 fusion protein activates non-canonical NF-κB signaling via rescued NIK in biliary tract cancerDawoon E Jung, Mi-Kyoung Seo, Jung Hyun Jo, et al.
International Journal of Cancer|June 3, 2022
A phase I/II study of ivaltinostat combined with gemcitabine and erlotinib in patients with untreated locally advanced or metastatic pancreatic adenocarcinomaJung Hyun Jo, Dawoon E Jung, Hee Seung Lee, et al.
Pageof 2